ABSTRACT
Noninvasive ventilation [NIV] is used extensively in acute and chronic settings, at home, and in hospitals. It plays a pivotal role in managing respiratory failure during the COVID-19 pandemic with robust use in hospitals to avert the need for intubation as well as reintubation. However, its use is associated with aerosol generation, which poses an immediate threat to all who work around it, like healthcare workers. Besides, domiciliary use is also associated with the same risk to the household and caregivers. Therefore, we need to plan the therapy and forge guidelines and recommendations to keep NIV safe during infections. Here we have reviewed the available literature and applied our experience to formulate guidelines and recommendations. However, updates and appraisals are evolving rapidly, and we need to keep our eyes open to tailor our approach. © 2022 by Nova Science Publishers, Inc. All rights reserved.